API China:Stimulate industry innovation vitality
On June 9, 2020, the 84th China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Fair (API China API) was opened in Qingdao World Expo City International Exhibition Center. API China API Exhibition was founded in 1968 and spent 52 years with the Chinese pharmaceutical industry. API China API is focused on serving the field of pharmaceutical R&D and production, and provides a product display and technology exchange platform for the entire industry chain and life cycle of pharmaceuticals, health nutrition products, and animal protection products. API China has now developed into an internationally renowned exhibition based in China and serving the world. It is a platform for excellent companies in China and the Asia-Pacific region to purchase products, exchange technology, understand industry information, and establish and maintain industry contacts.
In early 2020, in the face of the sudden new pneumonia epidemic, the Party Central Committee and the State Council led the people of the whole country, united as one, united as one, the epidemic prevention and control achieved important results, and the production and living order accelerated. Facing the challenge of epidemic situation, medical people are fearless retrograde and take their own actual actions to protect the health of the people, ensure the safety of the supply chain and ensure the stability of the industrial chain. At present, the Chinese pharmaceutical industry is also accelerating the resumption of production, and the resumption rate of enterprises above designated size exceeds 98%. General Secretary Xi Jinping mentioned in an important speech delivered by the leaders of the G20 in response to the New Coronary Pneumonia Special Summit: "China will increase its efforts to supply raw materials, necessities, and anti-epidemic materials to the international market." Every Chinese medicine person is taking practical actions to contribute to the stability of the supply chain of the global pharmaceutical industry chain!
API China API is a witness and promoter of the development of China's pharmaceutical industry. During this special period, it has joined hands with China Chemical and Pharmaceutical Industry Association, China Traditional Chinese Medicine Association, China Biochemical Pharmaceutical Industry Association, China Pharmaceutical Packaging Association, China Vaccine Industry Association, RDPAC , Dozens of pharmaceutical industry associations including the International Pharmaceutical Excipients Association, June 9-11, in Qingdao, Shandong, to create a safe, healthy and productive exhibition for the pharmaceutical industry, linking the supply chain of the industrial chain, and pressing the industry Recovery accelerator.
This year's API China has the theme of "linking the entire pharmaceutical industry chain, stimulating industry innovation, and positioning China's new future for pharmaceuticals". In response to the complex and ever-changing global environment, Chinese medical professionals have always upheld the concept of "bringing new opportunities in crisis and opening up new situations in the face of change", allowing difficulties to become opportunities for innovators and making the times a stage for strugglers. On June 9-11, more than 400 API companies, more than 100 pharmaceutical excipient companies, more than 180 pharmaceutical packaging companies, more than 200 pharmaceutical equipment companies, and more than 4,000 demand-side companies gathered in Qingdao to exchange face-to-face information, Efficiently link the supply chain industry chain, grasp the first-hand industry trust business opportunities. For the first time, this exhibition will showcase the latest technology and products in the field of pharmaceutical R&D and production to tens of thousands of pharmaceutical colleagues around the world who are unable to attend because of the epidemic through the new way of organizing exhibitions online and offline. More than 100 pharmaceutical industry experts will share the most cutting-edge knowledge and information for the global medical people through the API China pharmacist platform. API China is willing to join hands with all pharmaceutical colleagues to jointly position China's pharmaceutical future.

Exhibition of pharmaceutical raw materials
With the implementation of consistency evaluation and common review and approval of generic drugs, preparation companies, as the first person in charge of drug quality, will pay more attention to the improvement of product quality and deepen cooperation with excellent raw and auxiliary package suppliers. At the same time, the continuous improvement of environmental protection and safe production requirements has also put forward higher requirements for the entire pharmaceutical industry industrial chain. More than 400 leading pharmaceutical companies represented by Sinopharm Group, Tianyao Group, Shandong Xinhua, Qilu Pharmaceutical, Guobang Pharmaceutical, Huahai Pharmaceutical, Desha Pharmaceutical, and Erkang Pharmaceutical will bring their traditional advantages and products Newly developed new varieties gathered in Qingdao.
Natural extracts are the top among the products that have grown rapidly in China's pharmaceutical industry. The natural extracts area of this exhibition is for domestic and foreign preparations, health care products, food, and veterinary medicine companies, bringing together more than 80 mainstream domestic and foreign extract manufacturers. They will bring the latest natural extract products and market information to downstream buyers.
According to the person in charge of API China API, under the environment of continuous improvement of environmental protection and safe production requirements, the entire pharmaceutical API, intermediates, pharmaceutical and chemical industry chain is facing unprecedented challenges. However, the number of exhibitors and the scale of exhibits in the field of APIs at this year's exhibition remained at a high level, which also reflected from one side the urgent needs of industry colleagues to expand business opportunities after the epidemic. "Yuanmengxinxin, creating the future", welcome all pharmaceutical colleagues to visit the Qingdao World Expo City International Exhibition Center on June 9-11, and face to face with more than 400 Chinese excellent API, intermediates, pharmaceutical chemicals, extract companies Exchange and explore new trends and new opportunities in the field of raw materials and natural extracts in the Chinese pharmaceutical industry.
Exhibition of medicinal accessories
With the development of the consistency evaluation of oral solid preparations and injections, the problems of “high preparation process requirements”, “high evaluation cost”, and “time constraints” have become the problems faced by pharmaceutical companies.
China International Pharmaceutical Excipients/Functional Food Ingredients Exhibition (PHARMEX Excipient Ingredients Exhibition) is committed to providing solutions for Chinese pharmaceutical companies to pass consistency evaluations efficiently and quickly. More than 100 excellent excipient companies participated in this exhibition. Leading companies at home and abroad such as Hunan Erkang, Dalian Yejian, Ashland, Merck, Qingdao Yiqing, Yunhong Pharmaceutical Co., Ltd. will bring more than 1,000 kinds of pharmaceutical excipients. The product with the registration number appears. June 9-10, Seminar on consistency evaluation techniques and regulations for injection/oral solid preparations, IPEC (China) joint review and approval policy implementation seminar on pharmaceutical excipients, will provide Chinese pharmaceutical companies with efficient and rapid consistency evaluation The solution will escort the global distribution of Chinese drugs.
Pharmaceutical Packaging Museum|Intelligent packaging, innovation driven
According to experts' prediction, the size of China's pharmaceutical packaging market will exceed RMB 60 billion in 2021. As the first Asian pharmaceutical packaging exhibition-China International Pharmaceutical Packaging Exhibition (PHARMPACK Pharmaceutical Packaging Exhibition), which has lasted more than 30 years of development, it has become a grand event for pharmaceutical packaging brands of Asian pharmaceutical companies. This year's pharmaceutical packaging exhibition will take the theme of "intelligent packaging, innovation-driven" and launch a series of theme activities such as "new environment, new technology, new packaging-2020 pharmaceutical packaging innovation development forum", Chongqing Zhengchuan, Zhenmei Packaging, Four Star More than 180 domestic and foreign excellent pharmaceutical packaging manufacturers including glass, Taiji Printing, Renault Lite, and Hebei Rubber First will showcase more than 1,000 plastic packaging, packaging printing, medical rubber stoppers, bottle caps, aluminum foil aluminum plastic, and injection packaging materials. And other products to provide professional, comprehensive and convenient one-stop packaging procurement platform and complete packaging solutions for pharmaceutical, health care products, cosmetics, food, veterinary medicine production enterprises.
Pharmaceutical Equipment Exhibition|Technology Leads, Ingenious Medicine
In recent years, China Pharmaceutical has moved towards China's "intelligent" medicine. As a professional equipment product display platform serving the Chinese pharmaceutical field, China International Pharmaceutical Equipment Exhibition (hereinafter referred to as "Pharmaceutical Equipment Exhibition") brings together more than 200 leading pharmaceutical equipment at home and abroad enterprise. Jiangsu Saideli, Jiangsu Huada, Wuxi Zhanghua, Chongqing Patek, Shanghai Shengguan, Liaohe Pharmaceutical Machinery and other leading enterprises in the industry will all show their products at the exhibition. During this exhibition, a series of themed activities such as "Journey of Raw Drug Equipment" will also be launched to provide exhibitors with face-to-face exchanges with quality managers, equipment procurement personnel and enterprise executives of thousands of pharmaceutical and raw material manufacturing companies. opportunity.
Gather the voice of knowledge and transfer the power of technology
The sudden new coronary pneumonia epidemic in early 2020 pressed the "pause button" for all walks of life. Pharmaceutical people are fearless retrograde and take their own actual actions to protect the health of the people, ensure the safety of the supply chain, and ensure the stability of the industrial chain. This year, API China invited more than 100 industry experts to organize more than 20 high-quality and high-level conference forums through a new way of combining offline and online to discuss hot topics in the current environment. The content of the meeting included generic drug consistency evaluation, injection re-evaluation, joint review and approval, new drug development, MAH, product project, biopharmaceutical, pharmaceutical engineering and cleanliness, quality control, intelligent manufacturing, green pharmaceutical, environmental protection, animal health, pharmaceutical packaging Hot topics such as innovation and new trends in the global pharmaceutical industry! This API China exhibition has won the China Chemical and Pharmaceutical Industry Association, China Biochemical Pharmaceutical Industry Association, China Traditional Chinese Medicine Association, China Vaccine Industry Association, China Pharmaceutical Packaging Association, International Pharmaceutical Excipients Association, China Pharmaceutical Business Association, RDPAC, Shandong Pharmaceutical Industry The Association, the Qingdao Municipal Government, the West Coast New District Government, and the China Railway Expo City International Exhibition Center strongly supported. A number of partners such as HealthNet, FirstChemist, and Chebang have also held many high-quality conferences during the same period.
Starlight doesn't ask the passers-by, and the time is up to the strugglers. The 84th China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Trade Fair (API China) was held in this special period, which is not only a gas station to boost the confidence of the entire pharmaceutical industry, but also a starting point for industry transformation and upgrading under the new situation . Together, win the future. We are willing to work together with China's pharmaceutical industry to strengthen confidence and motivation, gather together the majestic strength of unity and struggle, link the entire pharmaceutical industry chain, stimulate the industry's innovation vitality, focus on quality and innovation, adhere to beliefs and original intentions, and jointly start a new journey of China's pharmaceutical industry. Positioning China's new pharmaceutical future!
Looking for chemical products? Let suppliers reach out to you!
2026-07-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Understand the New Rules to Enter the Market | ECHEMI × API China 2026 Overseas Pharmaceutical Market & Product Trends Conference Successfully Concluded
-
The 93rd API China
-
API China 2024: a new revolution in the pharmaceutical industry in a 69,000 square meter exhibition hall
-
API China 2024 opens grandly, pharmaceutical industry elites gather in Xi'an!
-
The 2024 Qingdao Seed Industry Expo will be held in June
-
The 89th API China & The 27th CHINA-PHARM Exhibition Opened Grandly at The Nanjing International Expo Center
-
2022 ECHEMI×API Virtual Business Matching
-
Vivo Capital Co-founded! Xinrui Won Exclusive Rights to 4 RNAi Drugs in Greater China
-
What Are The Industrial Uses Of Glycerin
-
Live report on ECHEMI × 87th API China
Recommend Reading
-
When Global Buyers No Longer Visit Trade Shows but “Select Suppliers with a Click”
-
When Global Buyers Sit at the Same Table, Chinese Suppliers Respond: A Real 1-on-1 Online Business Matching Event
-
ECHEMI and CPHI China Jointly Host Pharmaceutical Business Match-making Event
-
CPHI China 2026 Concludes Successfully, ECHEMI Serves Global Pharmaceutical Clients
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices
-
BASF Expands Architectural Coatings Dispersion Production Capacity in Turkey
-
Premium Global Chemical Sourcing Requests (4-8 Oct 2025)
-
Potassium Sorbate in Food: Safety, Uses, and Alternatives
-
Steel in the Hourglass: Germany’s “Protect-Steel” Proposal and the Green Calculation Behind It
-
Supply-side Disruptions Cause Dramatic Fluctuations in Lithium Carbonate Prices